HOWL (STOCKS)
Werewolf Therapeutics, Inc. Common Stock
$0.671100
-0.046600 (-6.49%)
Prev close: $0.717700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel J. Hicklin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $37.66M
- Employees
- 39
- P/E (TTM)
- -0.44
- P/B (TTM)
- 1.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.36 | $-0.40 | +0.0378 | +9.50% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.49 | +0.0855 | +17.61% |
|
Mar 2025 (Q1)
|
$-0.40 | $-0.40 | +0.0019 | +0.47% |
|
Dec 2024 (Q4)
|
$-0.46 | $-0.43 | -0.0333 | -7.80% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$1.23M |
| Operating Expenses | $71.61M |
| Research and Development | $53.62M |
| Other Operating Expenses | $17.98M |
| Operating Income/Loss | -$71.61M |
| Income/Loss From Continuing Operations After Tax | -$72.84M |
| Income/Loss From Continuing Operations Before Tax | -$72.84M |
| Net Income/Loss | -$72.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$72.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$72.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.62 |
| Diluted Earnings Per Share | -$1.60 |
| Basic Average Shares | 45,592,700 |
| Diluted Average Shares | 45,681,271 |
| Assets | $79.63M |
| Current Assets | $68.17M |
| Noncurrent Assets | $11.45M |
| Fixed Assets | $5.09M |
| Other Non-current Assets | $6.37M |
| Liabilities | $50.01M |
| Current Liabilities | $17.60M |
| Accounts Payable | $1.08M |
| Wages | $2.89M |
| Other Current Liabilities | $13.64M |
| Noncurrent Liabilities | $32.41M |
| Long-term Debt | $32.09M |
| Other Non-current Liabilities | $325.00K |
| Equity | $29.61M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.61M |
| Liabilities And Equity | $79.63M |
| Net Cash Flow From Operating Activities | -$63.52M |
| Net Cash Flow From Operating Activities, Continuing | -$63.52M |
| Net Cash Flow From Investing Activities | $45.48M |
| Net Cash Flow From Investing Activities, Continuing | $45.48M |
| Net Cash Flow From Financing Activities | $6.21M |
| Net Cash Flow From Financing Activities, Continuing | $6.21M |
| Net Cash Flow | -$11.83M |
| Net Cash Flow, Continuing | -$11.83M |
| Comprehensive Income/Loss | -$72.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$72.84M |
| Other Comprehensive Income/Loss | $0.00 |